Money Maker
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
On behalf of GB shareholders... How about showing that you care about OUR company and update GB's social media accounts... John or Andrea can do it while they are taking a dump... that's how easy it is.... you morons are getting paid enough... take care of business!... pathetic...
This and my last message was sent to GB through their website...
$GBLX
Andrea Small-Howard Executive Compensation... WTF are we doing here guys?...
Boom!...
$CVSI
Gap filled... $4.60 seems to be the sweet spot... march back up to $5.00... strapped in... like you mentioned... they're going to protect it hard... this is going to be fun to watch...
All IMO...
$GRWG
SEC Obtains Touting and Fraud Judgment Against Colorado Cannabis Stock Promoter
Washington D.C., Dec. 9, 2019 —
A Colorado stock promoter and two of his companies agreed to pay $4.2 million to settle the U.S. Securities and Exchange Commission's charges for fraudulently promoting and trading a cannabis stock. On Dec. 5, 2019, the U.S. District Court for the District of Colorado entered the final judgment.
The SEC's complaint alleged that Jeffrey O. Friedland touted – or promoted – the stock of cannabis company OWC Pharmaceutical Research Corp., while misrepresenting his own investment in OWC and his professional relationship with the company. According to the complaint, Friedland promoted OWC to investors without disclosing his role as a paid promoter or the amount of his compensation. As alleged in the complaint, Friedland held millions of shares of OWC stock through two companies that he controlled, Intiva Pharma LLC and Global Corporate Strategies LLC, with the bulk of the shares received as compensation for promoting OWC to investors, including retail investors. Additionally, according to the complaint, Friedland secretly sold his OWC shares into the market at the same time that he was touting OWC stock to the public as a long-term investment.
"Retail investors are entitled to the facts about promoters' relationships with the companies they tout under our securities laws," said Associate Director Melissa Hodgman. "The $2 million penalty assessed against Friedland reflects the SEC's strong commitment to protecting investors' right to fair and accurate disclosure."
Without admitting or denying the allegations in the complaint, Friedland and Global agreed to disgorge nearly $2.1 million plus prejudgment interest, and Intiva agreed to disgorge $20,000. Friedland also agreed to pay a $2 million penalty. All defendants consented to bars prohibiting them from participating in penny stock offerings.
The SEC's investigation was conducted by William Connolly, Michael Grimes, Keith O’Donnell, and Shipra Wells, with supervision from C. Joshua Felker. The litigation was conducted by Christian Schultz, Timothy Halloran, and Mr. Grimes, with supervision from Fred Block.
No reputable institution will buy penny stocks... especially this garbage... PERIOD!...
Show me one in 2020 that does... $5.00 is the threshold on this planet...
$OWCP
Stocks that trade below $5 are considered by Wall Street to be "penny stocks." These oft-derided, decidedly risky equities are populated by both illiquid, unlisted, wildly speculative "lottery ticket" companies that trade over-the-counter, and reputable companies that are either just beginning to grow or have perhaps fallen on hard times.
Stocks that trade below $5 are considered so risky that institutional investors, including pensions and mutual funds, aren't allowed to buy penny stocks and can even be required to sell securities that fall below the $5 mark. This double-edged sword cuts both ways, however, when an issue rises above $5 and institutions are allowed to buy.
This forms the basis of the $5 threshold trading strategy.
When stocks cross the $5 barrier in a bearish manner and institutions sell, the market is flooded with shares and the price is driven down. When a stock rises over that $5 threshold, institutions and hedge funds can, and sometimes do, load up on shares which in turn drives the price higher.
Um.... institutions don't buy penny stocks... this stock is being controlled by market makers who are manipulating and diluting into any strengthen... the only place this stock is running is into the ground... they have nothing... maybe a sharp trading bounce here or there... that's it...
They've been riding that BS PR piece for a month... no follow-up or plan... just selling shares to uninformed investors...
For the Three Month Periods Ended June 30, 2018 taken from a random 10Q...
Weighted average shares outstanding (diluted) 148,619,380... that number currently sits at over 260+ mil... not rocket science...
Link to 10Q... https://www.otcmarkets.com/filing/html?id=12922729&guid=V7djUWJiMHBOZ3h
Share structure 2018 - 2020... how many shares through toxic debt pumped in?... how many shares has the company sold... what is the increase in O/S over that time period... looking forward to your response... thanks champ... you're the best!
$OWCP
June 28 , 2018 / 47,500,000 were registered @ .23... Jump to Jan 7, 2020 / 262.3M and climbing... these numbers are indisputable!...
So what do these #'s mean?... MASSIVE DILUTION & ZERO chance of this making it past the recent high based on market cap logic alone.
Smart $ is out and on to the next idea... this is a setup to dump as many shares as they can on retail before the candle burns out... Smoke and mirrors with the latest PR... show me the $ (they have none)...
No way in hell this can support a 10mil market cap let alone 100's of millions... some of these predictions here are absolutely comical!... ;}
All IMO...
$OWCP
They pumped... I mean diluted... 100+ mil shares into circulation... those numbers are from past performance... it's all about market cap in this sector... 12m cap on this scam is reasonable... they have no money or plan and a story... just like most pinky's...
More pain to come here... lot's stuck in this believing in magic cream "approved" in a 3rd world country... kudos... very well orchestrated P&D to avoid legal action...
1.55 x 262.3m... you do the math... not attainable!... ever...
Been averaging down for quite some time... original buy-in in the $3's... lowest print .0512... average cost... .68... almost there!...
It would be painful to see this trade up just to break even...
Average cost... .68...
GL... you'll see $2.00 IMO sooner than later...
All IMO...
$TGODF
Hallelujah!... we broke .60... lol!... break even in sight...
$TGODF
Would like to see today's opening gap fill before heading higher...
All IMO...
$GRWG
Marching higher like we will cut through $5.00... weakness is being accumulated... I'm sure you see that chart is set up for a breakout...
L2 + T&S speaks volumes... The powers that be are running the show now...
All IMO...
$GRWG
Patience is paying off... green time... $$$...
$MJ...
Hitting a little resistance... $5.00 in sight... impressive support over the past month... I don't say this much but the stock deserves to be higher... I believe that time is upon us...
On another note... exchange partners aside, anyone else notice the increased number of Market Makers on the box?
$GRWG
Set up for a significant move higher... trend is reversing... this is ready to go!...
All IMO...
$CVSI
IMO this is ready to move higher... they are sitting on more cash than current market cap... one human trial announcement and we surge to a buck...
I have always traded this stock around their biotech model... growing weed was always secondary... too much of a commodity driven environment... proprietary formulas & drugs manufacturing... that's where the real $$ is... I like their current direction...
Biotech's are notorious for not saying much... they have been in this arena for quite some time... I also wouldn't be surprised to see a string of drug announcements over the next year...
Now a longer-term play... the reward potential has increased significantly... it only takes 1 drug in this arena to change the the complexion of a company...
Haven't had substantial news here in a while... wouldn't be surprised to see something shortly...
All IMO...
$GBLX
Slowly creeping higher... starting to gain some traction off of the low... though I own this... not sure if more than a 188m market cap is justified at this time...
No doubt they diluted this year in some capacity... my estimate is around 37 mil shares... Comparing spring 2019 to current numbers... 151 mil to 188mil... please correct me if I'm wrong...
All IMO...
$CNPOF
They skillfully trapped more people in this scam yesterday... ran the price on anemic volume toward the close... brought in the FOMO's on a strategic dead cat bounce... sub .02 coming...
$OWCP
Went through the financials again...
A lot less shares circulating out there than I originally thought... the stock is very tightly held...
Warrants at CAD $1.50 expiring in March 2020... IMO this trades up or close to parity...
The additional warrants expiring next year should be the last round of dilution... there aren't that many... I cant see that being a cap factor on SP... chart is firming up nicely for a true reversal...
All IMO...
$FFNTF
Anywhere above .01.... it's not worth the risk... even for a trade... been calling the short side along side of you... 10 foot pole rule on this one...
Buyer beware...
All IMO...
$OWCP
Sub .02 coming... not too much more to say... stick a fork in this...
All IMO...
$OWCP
They'll be looking to generate volume... legging down power hour... sub .05 close is not out of the question...
All IMO...
$OWCP
Hammer is about to drop... hanging on by a thread... gonna get ugly...
All IMO...
$OWCP
Last chance to exit before .02's... Big Friday selloff coming tomorrow.. Traders don't hold over weekends... this will be no different... hook or crook... anyone with size left will be out...
Volume is anemic... buy-side volume is nonexistent... it won't take long to reach .02's... One market maker on the box propping up the share price... I cant see them sticking around much longer either...
All IMO...
$OWCP
Time to go long here...
All IMO...
$CVSI...
DENVER , Jan. 9, 2020 /PRNewswire/ - GrowGeneration Corp. (NASDAQ: GRWG), ("GrowGen" or the "Company") the largest chain of specialty retail hydroponic and organic garden centers, with currently 26 locations, today announced CEO, Darren Lampert and President, Michael Salaman will speak at the ICR Conference 2020 on January 13, 2020 at 9:00 a.m. ET in Orlando, FL.
The presentations will be available on the Investors section of the Company's website at http://www.growgeneration.com/investor-relations/ ;
About GrowGeneration Corp.:
GrowGen owns and operates specialty retail hydroponic and organic gardening stores. Currently, GrowGen has 26 stores, which include 5 locations in Colorado , 5 locations in California , 2 locations in Nevada , 1 location in Washington , 4 locations in Michigan , 1 location in Rhode Island , 4 locations in Oklahoma,1 location in Oregon and 3 locations in Maine . GrowGen also operates an online superstore for cultivators, located at HeavyGardens.com. GrowGen carries and sells thousands of products, including organic nutrients and soils, advanced lighting technology and state of the art hydroponic equipment to be used indoors and outdoors by commercial and home growers. Our mission is to own and operate GrowGeneration branded stores in all the major states in the U.S. and Canada . Management estimates that roughly 1,000 hydroponic stores are in operation in the U.S. By 2020 the market is estimated to reach over $23 billion with a compound annual growth.
Opening gap filled... you'll have plenty of time to buy under .06...
All IMO...
$OWCP
Major dilutive shares pumped in over the past few days... the share price is being propped up by 1 market maker... the big $ has already been made on the front side... retail is picking apart the scraps at this point on the heels of a magic cream announcement...
.04-.05 range today...
All IMO...
$OWCP
Chart + Bear Flag = leg down...
.04 - .05 cent rage today... gonna get ugly... SP cuts through .0485...
All IMO...
$OWCP
SOL Global’s investment portfolio valued between $165.2 and $182.4 Million as at November 30, 2019
TORONTO --(BUSINESS WIRE)-- SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL) (OTCPK: SOLCF) (Frankfurt:9SB) is pleased to announce that Duff & Phelps Canada Limited (“ Duff & Phelps ”) has completed a valuation of the Company’s portfolio of private and public investments (the “Investment Portfolio”) as of November 30, 2019 (the “Valuation”). All dollar values within this news release are expressed in Canadian Dollars.
Duff & Phelps Valuation
Based upon the scope of review and subject to the assumptions, limitations and qualifications and other information set out in the Valuation, Duff & Phelps concluded that the value of the Investment Portfolio, as at November 30, 2019 , is in a range between $165.2 and $182.4 million with a midpoint of $173.8 million.
Pursuant to the terms of its engagement, Duff & Phelps prepared the Valuation in accordance with the standards of the CBV Institute solely for the information and use of the board of directors of SOL Global to assist it in connection with a strategic review of the Investment Portfolio and not for any other person and the Valuation may not be used or relied upon for any other purpose. The Valuation values only the Investment Portfolio, which comprises SOL Global’s investments in Verano Holdings, LLC , Canncure Investments Inc. , HeavenlyRx Ltd. , and other public and private company investments and debt instruments, with consideration of potential acquisitions that were at an advanced stage of due diligence. The Valuation does not include any other assets of SOL Global or factor in any of the Company’s liabilities, including its previously announced (on July 8, 2019 ) outstanding $50.0 million senior secured non-convertible debenture.
Commentary by SOL Global
SOL Global notes that the Valuation was completed at the end of the same month that the MJ ETF hit a record low price1, after declining by 45.64%. Over the same period, the benchmark S&P 500 index rose 16.90%. Management believes that this spread demonstrates that there still remains substantial room for accretion of SOL Global’s cannabis and CBD investments as the marketplace continues to mature.
“We are pleased with the results of the Duff & Phelps valuation as we believe it demonstrates the strength of our core business and our ability to dynamically manage our assets during what has been a transformational year for the cannabis industry. Despite a substantial downturn that hit the entire sector, we held fast to our positions. The strong valuation of our portfolio is a testament to the validity of our investment strategy and our portfolio of public and private companies that include a variety of THC-focused brands including One Plant Florida , and highlights our ability to invest in other complementary industries like CBD and Esports. It’s clear that SOL Global is positioned for future growth over time as the market rebounds and matures,” said SOL Global CEO Brady Cobb . “I’m particularly excited about our positive momentum in Florida through One Plant’s scaled growth and success in cultivating the best premium flower and flower derived products in the State. Their success is evidence of our commitment to operating at the highest levels in the space, all with a laser focus on creating shareholder value via efficient operations including our proprietary delivery model.”
SOL Global’s Net Asset Value (“NAV”) Calculation2:
Using the valuation midpoint of $173.8 million as reflected in the Valuation, and applying certain other assumptions deemed reasonable by management of SOL Global [and reflected below], the Company has calculated the net asset value of the Company as at November 30, 2019 :
$173.8M - Midpoint of Valuation of Investment Portfolio (as at November 30, 2019 )
$81.2M - Total liabilities per the September 30, 2019 , SOL Global’s financial statements as at and for the six-month period ended September 30, 2019 3
$92.6M - Net Asset Value
The Company currently has 54,459,256 common shares issued and outstanding on a non-diluted basis. This implies a NAV per Share of approximately $1.70 .
The foregoing calculation was prepared solely by management of SOL Global and is not part of the Valuation or any of the work conducted by Duff & Phelps .
___________________________________________ 1
https://www.marketwatch.com/story/cannabis-etf-falls-toward-record-low-longest-ever-losing-streak-of-8-sessions-2019-09-25 2 The calculation of the Net Asset Value is a non-IFRS measure. See non-IFRS measures below. 3 SOL Global provides no assurance that the liability balance presented in the unaudited financial statements as at and for the six-month period ended September 30, 2019 is reflective of the liability balance as at November 30, 2019 .
About SOL Global Investments Corp.
SOL Global is an international investment company with a focus on investing in cannabis and cannabis related companies in legal U.S. states, the hemp and CBD marketplaces and the emerging European cannabis and hemp marketplaces with an objective of providing shareholders with a long term return through capital appreciation, dividends and interest from its investments. If SOL Global believes there is a strategic reason to do so, it may also invest in companies not in the cannabis sector.
About Duff & Phelps
The independent valuation was conducted by Duff & Phelps Canada Limited , the Canadian operating subsidiary of Duff & Phelps, LLC , a global valuation and corporate finance advisory firm with expertise in business valuation, economic loss quantification, transaction opinions, mergers and acquisitions, disputes and investigations, restructuring, and compliance and regulatory consulting. Its clients include publicly traded and privately held companies, law firms, government entities and investment organizations such as private equity firms and hedge funds. Duff & Phelps also advises the world’s leading standard setting bodies on valuation issues and best practices. Duff & Phelps’ more than 3,500 professionals are located in over 70 offices in 28 countries around the world.
Non-IFRS Financial Measures
This press release includes references to net asset value and net asset value per share, which are financial measures that do not have a standardized meaning prescribed by IFRS. Net asset value is calculated as the value of total assets less the value of total liabilities at a specific date; net asset value per share is the value of the total assets less the value of total liabilities divided by the total number of common shares outstanding as at a specific date. The Company believes these non-IFRS financial measures not only provide management with comparable financial data for internal financial analysis but also provide meaningful supplemental information to investors. In particular, management believes these financial measures can provide information useful to its shareholders in understanding the performance of the Company and may assist in the evaluation of its business relative to that of its peers. Investors are cautioned that these non-IFRS measures should not be construed as an alternative to the measurements calculated in accordance with IFRS as, given their non-standardized meaning, they may not be comparable to similar measures presented by other issuers.
Advisory on Forward-Looking Information
This press release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as "may", "will", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussions of strategy. The forward-looking information contained herein include, but are not limited to, information relating to the Company’s strategic plans and business and its expectations regarding the future of the cannabis market.
By nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. Such factors include, but are not limited to: the Company's ability to comply with all applicable governmental regulations in a highly regulated business; investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under US federal laws; changes in laws; limited operating history; reliance on management; requirements for additional financing; competition; inconsistent public opinion and perception regarding the medical-use and adult-use marijuana industry; and regulatory or political change. Additional risk factors can also be found in the Company's current MD&A, which has been filed on SEDAR and can be accessed at www.sedar.com.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
4Front Ventures Begins Adult-Use Cannabis Sales in Chicago
https://marketexclusive.com/4front-ventures-begins-adult-use-cannabis-sales-in-chicago/2020/01/
Moving higher... nice to see this trading above the 50 day and 100day... looks like we have traction... next stop 200day...
All IMO...
Long $FFNTF
Good post... this is a great synopses of how the penny stock arena works in general...
This company was... is... and always be a scam... period... lipstick on a pig... we'll we know the rest...
I banked here many years ago... ran for the exit and never looked back... I would advise others to do the same... they will drive this back down to trips... ZERO chance of this moving north outside of another stock split... I guarantee it...
GL...
All IMO...
$ERBB
Just for fun...
Pound for pound... find me a better value in the 420 space...
$GRWG